PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

NCT04303117 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

80

Enrollment

NIH

Sponsor class

Conditions

Kaposi Sarcoma

Interventions

DRUG: PDS01ADC
DRUG: M7824

Sponsor

National Cancer Institute (NCI)